Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology.
about
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesContribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.New perspectives in the diagnosis of systemic fungal infections.Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCRA multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan.Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.Fusarium infection after solid-organ transplantation.Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies.Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention.The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure.Assessing risk factors for systemic fungal infections.Aspergillus fumigatus and related species.Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of TurkeyEndogenous Candida endophthalmitis.Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults.Skin infections in organ transplant recipients.Treatment of fungal bioaerosols by a high-temperature, short-time process in a continuous-flow systemPCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients.Aspergillus thyroiditis: a complication of respiratory tract infection in an immunocompromised patient.Modeling of thermodynamic and physico-chemical properties of coumarins bioactivity against Candida albicans using a Levenberg-Marquardt neural network.A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus.Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.Antifungal therapy in 'bone marrow failure'.Expression profiling of bioactive genes from a medicinal plant Nigella sativa L.Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis.Aspergillus endocarditis of the mitral valve in a lung-transplant patientForward Modeling of the Coumarin Antifungals; SPR/SAR Based Perspective.Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies.Systemic fusariosis after a preparative regimen including thiotepa, VP-16 and busulfan used for blood stem cell transplantation in Hodgkin's disease.Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis.Aggressive cutaneous aspergillus infection: control by local irrigation with amphotericin B.Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient.Quality of life, disability scores, and distress index in fungal rhinosinusitis.Fatal airway obstruction caused by invasive aspergillosis of the thyroid gland.Low incidence of candidaemia among neutropenic patients treated for haematological diseases.Detection of candidaemia in high risk patients: can yield of blood cultures be improved by blind subculture?Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B.
P2860
Q28077381-B8818366-4178-4E94-8C0C-223781E16C70Q33592749-F6939687-8611-4EBB-9BE3-BFA5D735D99EQ33780702-F23FE63C-AA40-4016-BF7C-7767E607B9F4Q33968780-8614A3BD-FFB4-4069-8397-0D0856289E28Q33980368-77BC0862-0003-4869-A53C-C1C4797F5514Q34069443-7E4A9275-1838-462C-BBFA-B664C848061DQ34205640-4C8E96CA-7CD2-4147-B1C6-2BF507EFF3CEQ34291656-EF955EEC-696D-4905-BDAC-D24141D59351Q34330077-92EAD1BC-B5FC-4BB4-B1B0-10F245E669CBQ34373864-AF13F305-7F86-4885-A004-BD731E438119Q34505274-A50E1575-5759-4F11-BD9C-C13C5BC70574Q34517136-9568D12F-5516-466D-97F9-87FC805BBA33Q35045054-5A67008F-B11D-474E-BAD9-4A3804FDB229Q36067125-BC51F1DD-219C-4BF9-9FCC-596E72DA4D2EQ36607424-62E0592D-39AC-43FA-B8CB-CC2E00BDF340Q36892250-5B434B89-D507-4B2D-8869-6645F8BFA900Q36998035-A9E0B07F-05F1-4C6F-B364-7CF7E899FB5CQ37191127-A7F7C556-9C9E-499E-AF87-E5AE7D51C57FQ37227160-A74ACE55-0636-4E55-BF46-CC5586999D35Q38181131-4AE8D19E-E1F4-42F5-A7E4-42B84ACB4DDAQ38364451-5E82DFE3-5D84-4E29-9A66-7FB3836D850FQ39617741-7FA58230-65C5-407D-97AB-49A116149C33Q40309090-9413EE8D-89DA-42A9-9F54-FB7B79BEABA2Q41480974-47E6BC3C-4586-4F22-89E0-D2ED9A0B06A5Q41733799-01E83C9A-672B-4C38-B652-14924D97B782Q42262534-DA471D3E-3545-4E02-B830-F77BA32401EAQ42285405-CE6A0114-1ED4-4086-96AC-9311A4147051Q42860898-E618BD7B-A6FF-4378-923F-DB58F1C1097BQ43060361-C404EF2A-ACD0-4124-BFFA-23E1DB7B3510Q43137240-28C76BC7-4D11-4550-BDB4-9E04F6E3456DQ43653748-E9CF77B1-1A0C-4011-ABDF-EF678ABFB269Q43732838-83331E37-D6C6-4CD5-BB14-74AE5B368B4EQ43839110-8BA97B00-0152-4C6D-86EE-F5DA84267349Q44063014-9BF2054A-30EE-47BB-BB7F-C9859D73957DQ46021264-BB27914C-7D46-455B-8351-1D089AB020AEQ48070663-2A74C791-23D1-4001-A79F-129A1CD9E430Q51191362-AF776A44-60E2-4327-BB0D-C0A1288DE004Q51193209-6ABE0BAC-FB08-454E-95A9-8F681FFF5D41Q51257593-52DB51FF-498F-42F0-89F8-10CDD81DF8D2Q52761081-F5768D93-7B84-4C89-8493-43EFB352A28A
P2860
Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Guidelines for the investigati ...... Society for Medical Mycology.
@en
type
label
Guidelines for the investigati ...... Society for Medical Mycology.
@en
prefLabel
Guidelines for the investigati ...... Society for Medical Mycology.
@en
P2093
P2860
P50
P356
P1476
Guidelines for the investigati ...... Society for Medical Mycology.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02471906
P577
1997-06-01T00:00:00Z
P6179
1039035670